Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global OAB Treatment Market Growth (Status and Outlook) 2022-2028

  • LP 4761030
  • 87 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of OAB Treatment will have significant change from previous year. According to our (LP Information) latest study, the global OAB Treatment market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global OAB Treatment market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States OAB Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global OAB Treatment market, reaching US$ million by the year 2028. As for the Europe OAB Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main OAB Treatment players cover Astellas Pharma, Allergan, Pfizer, and Teva (Activas), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of OAB Treatment market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Anticholinergics

Mirabegron

Botox

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Idiopathic Overactive Bladder

Neurogenic Overactive Bladder

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Astellas Pharma

Allergan

Pfizer

Teva (Activas)

Johnson & Johnson

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global OAB Treatment Market Size 2017-2028

2.1.2 OAB Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 OAB Treatment Segment by Type

2.2.1 Anticholinergics

2.2.2 Mirabegron

2.2.3 Botox

2.3 OAB Treatment Market Size by Type

2.3.1 OAB Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global OAB Treatment Market Size Market Share by Type (2017-2022)

2.4 OAB Treatment Segment by Application

2.4.1 Idiopathic Overactive Bladder

2.4.2 Neurogenic Overactive Bladder

2.5 OAB Treatment Market Size by Application

2.5.1 OAB Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global OAB Treatment Market Size Market Share by Application (2017-2022)

3 OAB Treatment Market Size by Player

3.1 OAB Treatment Market Size Market Share by Players

3.1.1 Global OAB Treatment Revenue by Players (2020-2022)

3.1.2 Global OAB Treatment Revenue Market Share by Players (2020-2022)

3.2 Global OAB Treatment Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 OAB Treatment by Regions

4.1 OAB Treatment Market Size by Regions (2017-2022)

4.2 Americas OAB Treatment Market Size Growth (2017-2022)

4.3 APAC OAB Treatment Market Size Growth (2017-2022)

4.4 Europe OAB Treatment Market Size Growth (2017-2022)

4.5 Middle East & Africa OAB Treatment Market Size Growth (2017-2022)

5 Americas

5.1 Americas OAB Treatment Market Size by Country (2017-2022)

5.2 Americas OAB Treatment Market Size by Type (2017-2022)

5.3 Americas OAB Treatment Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC OAB Treatment Market Size by Region (2017-2022)

6.2 APAC OAB Treatment Market Size by Type (2017-2022)

6.3 APAC OAB Treatment Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe OAB Treatment by Country (2017-2022)

7.2 Europe OAB Treatment Market Size by Type (2017-2022)

7.3 Europe OAB Treatment Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa OAB Treatment by Region (2017-2022)

8.2 Middle East & Africa OAB Treatment Market Size by Type (2017-2022)

8.3 Middle East & Africa OAB Treatment Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global OAB Treatment Market Forecast

10.1 Global OAB Treatment Forecast by Regions (2023-2028)

10.1.1 Global OAB Treatment Forecast by Regions (2023-2028)

10.1.2 Americas OAB Treatment Forecast

10.1.3 APAC OAB Treatment Forecast

10.1.4 Europe OAB Treatment Forecast

10.1.5 Middle East & Africa OAB Treatment Forecast

10.2 Americas OAB Treatment Forecast by Country (2023-2028)

10.2.1 United States OAB Treatment Market Forecast

10.2.2 Canada OAB Treatment Market Forecast

10.2.3 Mexico OAB Treatment Market Forecast

10.2.4 Brazil OAB Treatment Market Forecast

10.3 APAC OAB Treatment Forecast by Region (2023-2028)

10.3.1 China OAB Treatment Market Forecast

10.3.2 Japan OAB Treatment Market Forecast

10.3.3 Korea OAB Treatment Market Forecast

10.3.4 Southeast Asia OAB Treatment Market Forecast

10.3.5 India OAB Treatment Market Forecast

10.3.6 Australia OAB Treatment Market Forecast

10.4 Europe OAB Treatment Forecast by Country (2023-2028)

10.4.1 Germany OAB Treatment Market Forecast

10.4.2 France OAB Treatment Market Forecast

10.4.3 UK OAB Treatment Market Forecast

10.4.4 Italy OAB Treatment Market Forecast

10.4.5 Russia OAB Treatment Market Forecast

10.5 Middle East & Africa OAB Treatment Forecast by Region (2023-2028)

10.5.1 Egypt OAB Treatment Market Forecast

10.5.2 South Africa OAB Treatment Market Forecast

10.5.3 Israel OAB Treatment Market Forecast

10.5.4 Turkey OAB Treatment Market Forecast

10.5.5 GCC Countries OAB Treatment Market Forecast

10.6 Global OAB Treatment Forecast by Type (2023-2028)

10.7 Global OAB Treatment Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Astellas Pharma

11.1.1 Astellas Pharma Company Information

11.1.2 Astellas Pharma OAB Treatment Product Offered

11.1.3 Astellas Pharma OAB Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Astellas Pharma Main Business Overview

11.1.5 Astellas Pharma Latest Developments

11.2 Allergan

11.2.1 Allergan Company Information

11.2.2 Allergan OAB Treatment Product Offered

11.2.3 Allergan OAB Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Allergan Main Business Overview

11.2.5 Allergan Latest Developments

11.3 Pfizer

11.3.1 Pfizer Company Information

11.3.2 Pfizer OAB Treatment Product Offered

11.3.3 Pfizer OAB Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Pfizer Main Business Overview

11.3.5 Pfizer Latest Developments

11.4 Teva (Activas)

11.4.1 Teva (Activas) Company Information

11.4.2 Teva (Activas) OAB Treatment Product Offered

11.4.3 Teva (Activas) OAB Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Teva (Activas) Main Business Overview

11.4.5 Teva (Activas) Latest Developments

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Information

11.5.2 Johnson & Johnson OAB Treatment Product Offered

11.5.3 Johnson & Johnson OAB Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Johnson & Johnson Main Business Overview

11.5.5 Johnson & Johnson Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. OAB Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Anticholinergics

Table 3. Major Players of Mirabegron

Table 4. Major Players of Botox

Table 5. OAB Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global OAB Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global OAB Treatment Market Size Market Share by Type (2017-2022)

Table 8. OAB Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global OAB Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global OAB Treatment Market Size Market Share by Application (2017-2022)

Table 11. Global OAB Treatment Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global OAB Treatment Revenue Market Share by Player (2020-2022)

Table 13. OAB Treatment Key Players Head office and Products Offered

Table 14. OAB Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global OAB Treatment Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global OAB Treatment Market Size Market Share by Regions (2017-2022)

Table 19. Americas OAB Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas OAB Treatment Market Size Market Share by Country (2017-2022)

Table 21. Americas OAB Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas OAB Treatment Market Size Market Share by Type (2017-2022)

Table 23. Americas OAB Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas OAB Treatment Market Size Market Share by Application (2017-2022)

Table 25. APAC OAB Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC OAB Treatment Market Size Market Share by Region (2017-2022)

Table 27. APAC OAB Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC OAB Treatment Market Size Market Share by Type (2017-2022)

Table 29. APAC OAB Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC OAB Treatment Market Size Market Share by Application (2017-2022)

Table 31. Europe OAB Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe OAB Treatment Market Size Market Share by Country (2017-2022)

Table 33. Europe OAB Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe OAB Treatment Market Size Market Share by Type (2017-2022)

Table 35. Europe OAB Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe OAB Treatment Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa OAB Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa OAB Treatment Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa OAB Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa OAB Treatment Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa OAB Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa OAB Treatment Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of OAB Treatment

Table 44. Key Market Challenges & Risks of OAB Treatment

Table 45. Key Industry Trends of OAB Treatment

Table 46. Global OAB Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global OAB Treatment Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global OAB Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global OAB Treatment Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global OAB Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global OAB Treatment Market Size Market Share Forecast by Application (2023-2028)

Table 52. Astellas Pharma Details, Company Type, OAB Treatment Area Served and Its Competitors

Table 53. Astellas Pharma OAB Treatment Product Offered

Table 54. Astellas Pharma OAB Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. Astellas Pharma Main Business

Table 56. Astellas Pharma Latest Developments

Table 57. Allergan Details, Company Type, OAB Treatment Area Served and Its Competitors

Table 58. Allergan OAB Treatment Product Offered

Table 59. Allergan Main Business

Table 60. Allergan OAB Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. Allergan Latest Developments

Table 62. Pfizer Details, Company Type, OAB Treatment Area Served and Its Competitors

Table 63. Pfizer OAB Treatment Product Offered

Table 64. Pfizer Main Business

Table 65. Pfizer OAB Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Pfizer Latest Developments

Table 67. Teva (Activas) Details, Company Type, OAB Treatment Area Served and Its Competitors

Table 68. Teva (Activas) OAB Treatment Product Offered

Table 69. Teva (Activas) Main Business

Table 70. Teva (Activas) OAB Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Teva (Activas) Latest Developments

Table 72. Johnson & Johnson Details, Company Type, OAB Treatment Area Served and Its Competitors

Table 73. Johnson & Johnson OAB Treatment Product Offered

Table 74. Johnson & Johnson Main Business

Table 75. Johnson & Johnson OAB Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. Johnson & Johnson Latest Developments

List of Figures

Figure 1. OAB Treatment Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global OAB Treatment Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global OAB Treatment Market Size Market Share by Type in 2021

Figure 7. OAB Treatment in Idiopathic Overactive Bladder

Figure 8. Global OAB Treatment Market: Idiopathic Overactive Bladder (2017-2022) & ($ Millions)

Figure 9. OAB Treatment in Neurogenic Overactive Bladder

Figure 10. Global OAB Treatment Market: Neurogenic Overactive Bladder (2017-2022) & ($ Millions)

Figure 11. Global OAB Treatment Market Size Market Share by Application in 2021

Figure 12. Global OAB Treatment Revenue Market Share by Player in 2021

Figure 13. Global OAB Treatment Market Size Market Share by Regions (2017-2022)

Figure 14. Americas OAB Treatment Market Size 2017-2022 ($ Millions)

Figure 15. APAC OAB Treatment Market Size 2017-2022 ($ Millions)

Figure 16. Europe OAB Treatment Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa OAB Treatment Market Size 2017-2022 ($ Millions)

Figure 18. Americas OAB Treatment Value Market Share by Country in 2021

Figure 19. Americas OAB Treatment Consumption Market Share by Type in 2021

Figure 20. Americas OAB Treatment Market Size Market Share by Application in 2021

Figure 21. United States OAB Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada OAB Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico OAB Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil OAB Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC OAB Treatment Market Size Market Share by Region in 2021

Figure 26. APAC OAB Treatment Market Size Market Share by Application in 2021

Figure 27. China OAB Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan OAB Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea OAB Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia OAB Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 31. India OAB Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia OAB Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe OAB Treatment Market Size Market Share by Country in 2021

Figure 34. Europe OAB Treatment Market Size Market Share by Type in 2021

Figure 35. Europe OAB Treatment Market Size Market Share by Application in 2021

Figure 36. Germany OAB Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 37. France OAB Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK OAB Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy OAB Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia OAB Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa OAB Treatment Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa OAB Treatment Market Size Market Share by Type in 2021

Figure 43. Middle East & Africa OAB Treatment Market Size Market Share by Application in 2021

Figure 44. Egypt OAB Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa OAB Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel OAB Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey OAB Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country OAB Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 50. APAC OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 51. Europe OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 53. United States OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 54. Canada OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 55. Mexico OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 56. Brazil OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 57. China OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 58. Japan OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 59. Korea OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 61. India OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 62. Australia OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 63. Germany OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 64. France OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 65. UK OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 66. Italy OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 67. Russia OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 68. Spain OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 69. Egypt OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 70. South Africa OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 71. Israel OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 72. Turkey OAB Treatment Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries OAB Treatment Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390